➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Aramchol

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Aramchol?

Aramchol is an investigational drug.

There have been 11 clinical trials for Aramchol. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2019.

The most common disease conditions in clinical trials are Fatty Liver, Non-alcoholic Fatty Liver Disease, and Liver Diseases. The leading clinical trial sponsors are Galmed Pharmaceuticals Ltd, Tel-Aviv Sourasky Medical Center, and Diamond Pharma Services.

There are forty-three US patents protecting this investigational drug and five hundred and fifteen international patents.

Recent Clinical Trials for Aramchol
Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic ImpairmentGalmed Research and Development, Ltd.Phase 1
A Phase 3/4 Clinical Study to Evaluate the Efficacy and Safety of Aramchol Versus Placebo in Subjects With NASH (ARMOR)Galmed Research and Development, Ltd.Phase 3
Comparison of Aramchol Concentrations With Once or Twice Daily DosingAnalyst Research LaboratoriesPhase 1

See all Aramchol clinical trials

Clinical Trial Summary for Aramchol

Top disease conditions for Aramchol
Top clinical trial sponsors for Aramchol

See all Aramchol clinical trials

US Patents for Aramchol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Aramchol   Get Started Free Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists Bristol-Myers Squibb Company (Princeton, NJ) Syngene International Limited (Bangalore, Karnataka, IN)   Get Started Free
Aramchol   Get Started Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Get Started Free
Aramchol   Get Started Free Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors Pfizer Inc. (New York, NY)   Get Started Free
Aramchol   Get Started Free Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof Gilead Apollo, LLC (Foster City, CA)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Aramchol

Drugname Country Document Number Estimated Expiration Related US Patent
Aramchol Argentina AR108838 2036-06-21   Get Started Free
Aramchol Australia AU2017281439 2036-06-21   Get Started Free
Aramchol Brazil BR112018076558 2036-06-21   Get Started Free
Aramchol Canada CA3029202 2036-06-21   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.